Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Donor”

2,763 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,763 results

Not applicableUnknownNCT04351945
What this trial is testing

Endocrine Changes and Their Correction in Heart and Lung Transplant Recipients and Donors

Who this might be right for
Endocrine System DiseasesThyroid DiseasesCortisol Deficiency+3 more
Semmelweis University Heart and Vascular Center 100
Post-approval studies (Phase 4)UnknownNCT01095172
What this trial is testing

RituxiMab INDuction in Renal Transplantation

Who this might be right for
Function of Renal Transplant
Guy's and St Thomas' NHS Foundation Trust 100
Not applicableEnded earlyNCT04829331
What this trial is testing

Utility of Restrata With Split Thickness Skin Graft to Reconstruct the Forearm Donor Site

Who this might be right for
Wound Heal
Acera Surgical, Inc. 5
Not applicableStudy completedNCT00521430
What this trial is testing

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Asan Medical Center 30
Early research (Phase 1)Study completedNCT00092937
What this trial is testing

Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant

Who this might be right for
Granulomatous DiseaseChronic
National Institute of Allergy and Infectious Diseases (NIAID) 2
Not applicableUnknownNCT03850119
What this trial is testing

Nanofat on Wound Healing and Scar Formation

Who this might be right for
ScarsDelayed Wound HealingHypertrophic Scar+2 more
Universitair Ziekenhuis Brussel 15
Large-scale testing (Phase 3)Study completedNCT02329457
What this trial is testing

VZV Vaccine for Hematopoietic Stem Cell Transplantation

Who this might be right for
Varicella Zoster Infection
The University of Hong Kong 100
Post-approval studies (Phase 4)Study completedNCT03294109
What this trial is testing

Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy

Who this might be right for
Pain, PostoperativeAnalgesics, OpioidAnalgesics, Non-Narcotic+5 more
University of California, Los Angeles 146
Not applicableStudy completedNCT04250298
What this trial is testing

Sucrosom5al Iron Supplementation in Blood Donors

Who this might be right for
Iron-deficiency
Medical University of Graz 50
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Not Yet RecruitingNCT07254793
What this trial is testing

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

Who this might be right for
Acute Lymphoid LeukemiaAcute Myeloid LeukemiaAcute Undifferentiated Leukemia (AUL)+3 more
University of Arizona 94
Large-scale testing (Phase 3)UnknownNCT04000698
What this trial is testing

Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute Leukemias

Who this might be right for
Refractory Acute Myeloid LeukemiaRefractory Acute Lymphoblastic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 25
Testing effectiveness (Phase 2)WithdrawnNCT01652014
What this trial is testing

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more
University of Medicine and Dentistry of New Jersey
Not applicableUnknownNCT01252784
What this trial is testing

Reduced-intensity Conditioning Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Myelodysplastic Syndrome
Cooperative Study Group A for Hematology 20
Not applicableStudy completedNCT04068363
What this trial is testing

Donor Gender Effect on Graft Function in Adult Egyptian Patients Undergoing Living Donor Liver Transplant

Who this might be right for
Donor to Recipient Gender Mismatch in LDLT
Ain Shams University 342
Not applicableStudy completedNCT02867293
What this trial is testing

Impact Of Timing Of Drainage Of Massive Ascites On Operative And Post-Operative Course In Living-Donor Liver Transplant Recipients. A Prospective Randomized Controlled Trial.

Who this might be right for
Massive Ascites
Mansoura University 80
Testing effectiveness (Phase 2)Looking for participantsNCT07510828
What this trial is testing

PRISM-NK: Precision-Matched Allogeneic Single- or Dual-Target CAR-NK Cells for Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Beijing Biotech 60
Testing effectiveness (Phase 2)WithdrawnNCT03602898
What this trial is testing

Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeChronic Myelomonocytic Leukemia+10 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01839916
What this trial is testing

Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more
University of Chicago 77
Testing effectiveness (Phase 2)UnknownNCT01332006
What this trial is testing

Intra-bone Cord Blood Transplantation

Who this might be right for
Hematologic Neoplasms
Università degli Studi di Brescia 17
Load More Results